SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015969
Filing Date
2023-06-20
Accepted
2023-06-20 16:16:32
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4008
  Complete submission text file 0000899243-23-015969.txt   5396
Mailing Address C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301
Business Address
Sandor Victor (Reporting) CIK: 0001620368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 231025304

Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)